Over $200 million has been spent by bio-artificial pancreas ventures. No product is on the market.

We estimate:

	$ million
Bio-Hybrid Technologies	$11
Damon (including Damon Biotech)	$45
Encelle	$8
Islet Technology	$5
Neocrin Company (including Baxter & Cytotherapeutics)	$85
VivoRx	$55
Total	$217